Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biovail Corporation
Biovail Announces Litigation Settlement
January 10th, 2009
Biovail Corporation (NYSE:BVF)(TSX:BVF) announced that a settlement agreement has been reached to resolve all outstanding litigation involving former Banc of America Securities analyst Jerry I. Treppel, including all claims asserted against the Company by Mr. Treppel, and all claims by and against each of Eugene Melnyk and Mr. Treppel. The litigation originally commenced in April 2003. The terms of the settlement are confidential; however, they are not material to Biovail’s cash flows or operating results. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and...
Source: Law & Health Weekly (2009-01-10)
|